Answers are grounded in this paper and cite their sources.
Prostate-specific membrane antigen–targeted PET agents are mainly used for prostate cancer; however, uptake in non-prostatic inflammatory tissue can challenge the physician. We report the case of a 75-year-old man referred for characterization of an FDG-avid prostate focus with normal PSA. 18 F-DCFPyL PET/CT was performed. Incidental moderate symmetric uptake was found in the pelvic-girdle and paravertebral muscles, without morphologic correlate on CT. Elevated creatine kinase, a late scleroderma-pattern capillaroscopy, and muscle MRI confirmed scleroderma-associated myositis. This case emphasizes that symmetric muscular prostate-specific membrane antigen uptake can reveal active inflammatory myositis.
No takes yet. Share an insight, caveat, or question.
Bailly et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: